Concepedia

C Malcolm

CM

Statistics

Publications

6

Citations

579

H-Index

6

Active since

1996

Affiliations

Roche (Switzerland)(Current)

C Malcolm is an author at Roche (Switzerland) specializing in pharmacology, medicine, and 5-hydroxytryptamine receptor pharmacology.

ORCID

Publications per year

1996–2005

6

Publications

6

Functional characterization of agonists at recombinant human 5‐HT<sub>2A</sub>, 5‐HT<sub>2B</sub> and 5‐HT<sub>2C</sub> receptors in CHO‐K1 cells

Richard H. Porter, Karen Benwell, Helen Lamb et al. · British Journal of Pharmacology · 1999 · 356 citations · Full text

, , +17

Modulation of 5-HT2A receptor-mediated head-twitch behaviour in the rat by 5-HT2C receptor agonists

S P Vickers, Neil Easton, C Malcolm et al. · Pharmacology Biochemistry and Behavior · 2001 · 112 citations

, , +10

Indoline derivatives as 5-HT 2C receptor agonists

Jonathan Bentley, David R. Adams, David Bebbington et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 44 citations · Full text

, , +16

Synthesis and biological evaluation of novel hexahydro-pyrido[3′,2′:4,5]pyrrolo[1,2-a]pyrazines as potent and selective 5-HT2C receptor agonists

Hans Richter, David R. Adams, Agnès Bénardeau et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 31 citations · Full text

, , +14

Identification of 4-methyl-1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles as 5-HT2C receptor agonists

Stephan Röver, David R. Adams, Agnès Bénardeau et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 21 citations · Full text

, , +12

1–5 of 6